- Home
- PGEN vs REPX Comparison
PGEN vs REPX Comparison
Compare PGEN & REPX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PGEN
- REPX
- Stock Information
- Founded
- PGEN 1998
- REPX 2016
- Country
- PGEN United States
- REPX United States
- Employees
- PGEN N/A
- REPX N/A
- Industry
- PGEN Biotechnology: Pharmaceutical Preparations
- REPX Oil & Gas Production
- Sector
- PGEN Health Care
- REPX Energy
- Exchange
- PGEN Nasdaq
- REPX Nasdaq
- Market Cap
- PGEN 493.0M
- REPX 581.0M
- IPO Year
- PGEN N/A
- REPX N/A
- Fundamental
- Price
- PGEN $3.28
- REPX $27.82
- Analyst Decision
- PGEN Buy
- REPX Strong Buy
- Analyst Count
- PGEN 5
- REPX 1
- Target Price
- PGEN $7.50
- REPX $47.00
- AVG Volume (30 Days)
- PGEN 5.8M
- REPX 118.8K
- Earning Date
- PGEN 11-13-2025
- REPX 11-05-2025
- Dividend Yield
- PGEN N/A
- REPX 5.43%
- EPS Growth
- PGEN N/A
- REPX N/A
- EPS
- PGEN N/A
- REPX 4.52
- Revenue
- PGEN $4,340,000.00
- REPX $392,885,000.00
- Revenue This Year
- PGEN $249.10
- REPX N/A
- Revenue Next Year
- PGEN $710.03
- REPX $8.97
- P/E Ratio
- PGEN N/A
- REPX $6.19
- Revenue Growth
- PGEN N/A
- REPX N/A
- 52 Week Low
- PGEN $0.65
- REPX $21.98
- 52 Week High
- PGEN $5.23
- REPX $37.55
- Technical
- Relative Strength Index (RSI)
- PGEN 46.00
- REPX 51.14
- Support Level
- PGEN $3.37
- REPX $26.21
- Resistance Level
- PGEN $4.00
- REPX $27.48
- Average True Range (ATR)
- PGEN 0.25
- REPX 0.99
- MACD
- PGEN -0.12
- REPX -0.05
- Stochastic Oscillator
- PGEN 21.08
- REPX 52.90
About PGEN Precigen Inc.
Precigen Inc is a biotechnology company that develops synthetic biology solutions. The company designs build and regulate gene programs. Its technologies are broadly applicable across a wide range of diverse end markets. Intrexon's business model is to commercialize its technologies through exclusive channel collaborations with collaborators that have specific industry expertise, development resources, and sales and marketing capabilities, in order to bring new and improved products and processes to market. Its reportable segments are Biopharmaceuticals and Exemplar. The company's collaborators provide compensation through technology access fees, royalties, milestones, and reimbursement of certain costs.
About REPX Riley Exploration Permian Inc.
Riley Exploration Permian Inc is engaged in the business of exploration for and production of oil and natural gas. The company operations are in Kansas Properties and Tennessee Properties, among others.